Finanzierungsrunde
News
Customs Window Technologies successful with 800,000 euros seed
Customs Window Technologies receives €800,000 to tackle customs clearance challenges in the EU and UK
News
Broswarm secures 800,000 euros
Broswarm has secured first place in the NATO innovation competition with the X-Ray Eagle. The innovative technology offers 3D visualization and thus enables fast and safe mine clearance.
News
The Female Company launches crowdinvesting campaign via WIWIN
The Berlin-based FemCare start-up raises 1.5 million euros via WIWIN for sustainable feminine hygiene products and international expansion.
News
iDWELL receives 10 million euros investment
Knight Capital and existing investors strengthen the PropTech company with EUR 10 million for platform expansion and service development.
News
Cloudsquid receives 1 million US dollars in pre-seed funding
New approach to data integration: Cloudsquid offers a universal API that frees companies from time-consuming paperwork.
News
Startupnews week 44 - 2024
Infraspeak receives 18 million euros. Dataciders takes over ROITI. ROCKWOOL acquires Wetherby Building Systems Ltd. Innomost appoints Tiina Bensky as CEO. thermondo appoints Josef Gatzek as new CFO. VEAN TATTOO...
News
12 million US dollars Series A for Modash
Global growth company Modash, partner to Birkenstock, Victoria's Secret and Farfetch, is investing in an AI-powered platform and simplified payment processes to take creator partnerships to the next level.
News
Nuuron secures million-euro investment for the development of a digital Alzheimer's drug
Nuuron's digital memory pacemaker promises to improve memory functions in Alzheimer's patients - investors such as HTGF and RoX Health are enthusiastic.
News
TXN Systems receives SEK 25 million in Series A funding
TXN Systems secures capital to advance EbsArgent™, a combined antibiotic with silver ions and ebselen, against multidrug-resistant bacteria in clinical trials.
News
SynOx Therapeutics increases capital to USD 92 million in Series B financing
Gilde Healthcare leads Series B extension and supports Phase 3 TANGENT study for emactuzumab, a promising CSF-1R-targeted therapy for tenosynovial giant cell tumor
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
FYI: English edition available
Hello my friend, have you been stranded on the German edition of Startbase? At least your browser tells us, that you do not speak German - so maybe you would like to switch to the English edition instead?
FYI: Deutsche Edition verfügbar
Hallo mein Freund, du befindest dich auf der Englischen Edition der Startbase und laut deinem Browser sprichst du eigentlich auch Deutsch. Magst du die Sprache wechseln?